Shenzhen Weiguang Biological Products Co Ltd Asset Resilience Ratio

Latest as of June 2024: 5.52%

Shenzhen Weiguang Biological Products Co Ltd asset resilience ratio. Shenzhen Weiguang Biological Products Co Ltd (002880) has an Asset Resilience Ratio of 5.52% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002880 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥169.93 Million

≈ $24.87 Million USD Cash + Short-term Investments

Total Assets

CN¥3.08 Billion

≈ $450.47 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shenzhen Weiguang Biological Products Co Ltd (2020–2024)

Asset resilience ratio of Shenzhen Weiguang Biological Products Co Ltd from 2020 to 2024. This chart shows how Shenzhen Weiguang Biological Products Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Shenzhen Weiguang Biological Products Co for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Weiguang Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Shenzhen Weiguang Biological Products Co.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥169.93 Million	5.52%
Total Liquid Assets	CN¥169.93 Million	5.52%

Asset Resilience Insights

Limited Liquidity: Shenzhen Weiguang Biological Products Co Ltd maintains only 5.52% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Weiguang Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Weiguang Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Shenzhen Weiguang Biological Products Co Ltd Asset Resilience Ratio by Year (2020–2024)

Shenzhen Weiguang Biological Products Co Ltd asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for Shenzhen Weiguang Biological Products Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.65%	CN¥153.32 Million ≈ $22.43 Million	CN¥3.30 Billion ≈ $482.52 Million	+27.52pp
2023-12-31	-22.87%	CN¥-658.04 Million ≈ $-96.29 Million	CN¥2.88 Billion ≈ $420.96 Million	-15.75pp
2022-12-31	-7.12%	CN¥-183.51 Million ≈ $-26.85 Million	CN¥2.58 Billion ≈ $376.91 Million	-5.95pp
2021-12-31	-1.17%	CN¥-23.53 Million ≈ $-3.44 Million	CN¥2.00 Billion ≈ $293.18 Million	-0.94pp
2020-12-31	-0.23%	CN¥-4.25 Million ≈ $-621.91K	CN¥1.84 Billion ≈ $268.69 Million	--

pp = percentage points

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$661.44 Million

CN¥4.52 Billion CNY

Market Cap Rank

#10473 Global

#2758 in China

Share Price

CN¥19.93

Change (1 day)

-0.05%

52-Week Range

CN¥18.80 - CN¥31.04

All Time High

CN¥963796.17